A Study of Prasugrel in Pediatric Participants With Sickle Cell Disease (SCD)

This study has been terminated.
(The study is being terminated for lack of efficacy.)
Sponsor:
Collaborator:
Daiichi Sankyo Inc.
Information provided by (Responsible Party):
Eli Lilly and Company
ClinicalTrials.gov Identifier:
NCT01794000
First received: February 14, 2013
Last updated: January 8, 2016
Last verified: January 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: November 2015
  Primary Completion Date: July 2015 (Final data collection date for primary outcome measure)